Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB1724 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#MAB1724, RRID:AB_1671596
- Product name
- AGER monoclonal antibody, clone 1C5
- Antibody type
- Monoclonal
- Description
- Mouse monoclonal antibody raised against recombinant AGER.
- Isotype
- IgG
- Antibody clone number
- 1C5
- Storage
- Store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases.
The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Acute lung injury as an adverse event of gefitinib.
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.
Koyama H, Yamamoto H, Nishizawa Y
Molecular medicine (Cambridge, Mass.) 2007 Nov-Dec;13(11-12):625-35
Molecular medicine (Cambridge, Mass.) 2007 Nov-Dec;13(11-12):625-35
The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F, Sorci G, Donato R
The Journal of biological chemistry 2006 Mar 24;281(12):8242-53
The Journal of biological chemistry 2006 Mar 24;281(12):8242-53
Acute lung injury as an adverse event of gefitinib.
Inomata S, Takahashi H, Nagata M, Yamada G, Shiratori M, Tanaka H, Satoh M, Saitoh T, Sato T, Abe S
Anti-cancer drugs 2004 Jun;15(5):461-7
Anti-cancer drugs 2004 Jun;15(5):461-7
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H
The Biochemical journal 2003 Mar 15;370(Pt 3):1097-109
The Biochemical journal 2003 Mar 15;370(Pt 3):1097-109
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.
Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM
Nature 2000 May 18;405(6784):354-60
Nature 2000 May 18;405(6784):354-60
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis of extract from CHO cells, using AGER monoclonal antibody, clone 1C5 (Cat # MAB1724) .
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Immunocytochemistry analysis of CHO cells overexpressing human AGER, using AGER monoclonal antibody, clone 1C5 (Cat # MAB1724) .
- Validation comment
- Immunocytochemistry
